PMCC Resources

Here are the staff publications for February 2018.

Compiled by the Health Sciences Library (RMH, RWH, PMCC and Victorian Mental Health) 5th March 2018.

 

  1. Brennan AJ, Law RHP, Conroy PJ, Noori T, Lukoyanova N, Saibil H, Yagita H, Ciccone A, Verschoor S, Whisstock JC, Trapani JA, Voskoboinik I. Perforin proteostasis is regulated through its C2 domain: supra-physiological cell death mediated by T431D-perforin. Cell Death and Differentiation 2018.

  2. Corona SP, Generali D. Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2- advanced breast cancer. Drug Des Devel Ther 2018;12:321-30.

  3. de Boer SM, Wortman BG, Bosse T, Powell ME, Singh N, Hollema H, Wilson G, Chowdhury MN, Mileshkin L, Pyman J, Katsaros D, Carinelli S, Fyles A, McLachlin CM, Haie-Meder C, Duvillard P, Nout RA, Verhoeven-Adema KW, Putter H, Creutzberg CL, Smit V, for PSG. Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer. Annals of Oncology 2018;29:424-30.

  4. Ferdinandus J, Violet J, Sandhu S, Hofman MS. Prostate-specific membrane antigen theranostics: therapy with lutetium-177. Curr Opin Urol 2018;28:197-204.

  5. Gandhidasan S, Ball D, Kron T, Bressel M, Shaw M, Chu J, Chander S, Wheeler G, Plumridge N, Chesson B, David S, Siva S. Single Fraction Stereotactic Ablative Body Radiotherapy for Oligometastasis: Outcomes from 132 Consecutive Patients. Clinical Oncology (R Coll Radiol) 2018;30:178-84.

  6. Garsed DW, Alsop K, Fereday S, Emmanuel C, Kennedy CJ, Etemadmoghadam D, Gao B, Gebski V, Gares V, Christie EL, Wouters MCA, Milne K, George J, Patch AM, Li J, Arnau GM, Semple T, Gadipally SR, Chiew YE, Hendley J, Mikeska T, Zapparoli GV, Amarasinghe K, Grimmond SM, Pearson JV, Waddell N, Hung J, Stewart CJR, Sharma R, Allan PE, Rambau PF, McNally O, Mileshkin L, Hamilton A, Ananda S, Grossi M, Cohen PA, Leung YC, Rome RM, Beale P, Blomfield P, Friedlander M, Brand A, Dobrovic A, Kobel M, Harnett P, Nelson BH, Bowtell DDL, deFazio A, Nadia Traficante ftAOCSG. Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer. Clinical Cancer Research 2018;24:569-80.

  7. Generali D, Corona SP, Pusztai L, Rouzier R, Allevi G, Aguggini S, Milani M, Strina C, Frati A. Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR. Journal of Cancer Research and Clinical Oncology 2018;144:601-6.

  8. Guerra GR, Kong JC, Bernardi MP, Ramsay RG, Phillips WA, Warrier SK, Lynch AC, Ngan SY, Heriot AG. Salvage Surgery for Locoregional Failure in Anal Squamous Cell Carcinoma. Diseases of the Colon and Rectum 2018;61:179-86.

  9. Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjaer SK, Hogdall E, Jensen A, Schildkraut JM, Berchuck A, Cramer DW, Bandera EV, Wentzensen N, Kotsopoulos J, Narod SA, Phelan CM, McLaughlin JR, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Terry KL, Ovarian Cancer Association C, Australian Ovarian Cancer Study G. Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention 2018;27:174-82.

  10. Harvey Y, Bleakley S, Blombery P, Bain BJ. Marked leukemoid reaction in a patient with metastatic breast carcinoma. American Journal of Hematology 2018;93:306-7.

  11. Hegi-Johnson F, Keall P, Barber J, Bui C, Kipritidis J. Evaluating the accuracy of 4D-CT ventilation imaging: First comparison with Technegas SPECT ventilation. Medical Physics 2017;44:4045-55.

  12. Hendry S, Byrne DJ, Wright GM, Young RJ, Sturrock S, Cooper WA, Fox SB. Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer. Journal of Thoracic Oncology 2018;13:367-76.

  13. Hicks RJ. The Injustice of Being Judged by the Errors of Others: The Tragic Tale of the Battle for PET Reimbursement. Journal of Nuclear Medicine 2018;59:418-20.

  14. Hugo HJ, Zysk A, Dasari P, Britt K, Hopper JL, Stone J, Thompson EW, Ingman WV. InforMD: a new initiative to raise public awareness about breast density. Ecancermedicalscience 2018;12:807.

  15. Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE, Jr., Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB. HER kinase inhibition in patients with HER2- and HER3-mutant cancers. Nature 2018;554:189-94.

  16. Jackson JT, Ng AP, Shields BJ, Haupt S, Haupt Y, McCormack MP. Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice. Blood Adv 2018;2:347-60.

  17. Johnson CE, Bennett KS, Newton J, McTigue J, Taylor S, Musiello T, Lau PKH. A pilot study to assess the validity of the DASS-21 subscales in an outpatient oncology population. Psycho-Oncology 2018;27:695-9.

  18. Lamboley CR, Xu H, Dutka TL, Hanson ED, Hayes A, Violet JA, Murphy RM, Lamb GD. Effect of androgen deprivation therapy on the contractile properties of type I and type II skeletal muscle fibres in men with non-metastatic prostate cancer. Clin Exp Pharmacol Physiol 2018;45:146-54.

  19. Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, Corry J, Grau C, Gregoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Soong YL, Tao Y, Yom SS, Wee JT. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiotherapy & Oncology 2018;126:25-36.

  20. Lee CHA, Kong JC, Ismail H, Riedel B, Heriot A. Systematic Review and Meta-analysis of Objective Assessment of Physical Fitness in Patients Undergoing Colorectal Cancer Surgery. Diseases of the Colon and Rectum 2018;61:400-9.

  21. Lipson-Smith R, Hyatt A, Murray A, Butow P, Hack TF, Jefford M, Ozolins U, Hale S, Schofield P. Measuring recall of medical information in non-English-speaking people with cancer: A methodology. Health Expectations 2018;21:288-99.

  22. Lo SN, Sandhu S. Reply to M. Horiguchi et al. Journal of Clinical Oncology 2018;36:722-3.

  23. Luen SJ, Loi S. Investigating the role of tumor-infiltrating lymphocytes in advanced HER2-positive breast cancer. Chin Clin Oncol 2018;7:2.

  24. Manning TG, Papa N, Perera M, McGrath S, Christidis D, Khan M, O'Beirne R, Campbell N, Bolton D, Lawrentschuk N. Laparoscopic lens fogging: solving a common surgical problem in standard and robotic laparoscopes via a scientific model. Surgical Endoscopy 2018;32:1600-6.

  25. Masaldan S, Clatworthy SAS, Gamell C, Meggyesy PM, Rigopoulos AT, Haupt S, Haupt Y, Denoyer D, Adlard PA, Bush AI, Cater MA. Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox Biol 2018;14:100-15.

  26. Mastaglio S, Wong E, Perera T, Ripley J, Blombery P, Smyth MJ, Koldej R, Ritchie D. Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy. Blood Adv 2018;2:335-46.

  27. Natanzon Y, Earp M, Cunningham JM, Kalli KR, Wang C, Armasu SM, Larson MC, Bowtell DD, Garsed DW, Fridley BL, Winham SJ, Goode EL. Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer. Cancer Inform 2018;17:1176935118755341.

  28. Nguyen-Dumont T, Teo ZL, Hammet F, Roberge A, Mahmoodi M, Tsimiklis H, Park DJ, Pope BJ, Lonie A, Kapuscinski MK, Mahmood K, Abcfr, Goldgar DE, Giles GG, Winship I, Hopper JL, Southey MC. Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations? BMC Cancer 2018;18:165.

  29. Opat S, Hearps AC, Thia K, Yuen A, Rogers B, Chachage M, Moore G, Shortt J, Ryland G, Blombery P, Schwarer AP, Noori T, Trapani JA, Jaworowski A, Voskoboinik I. Adaptive reprogramming of NK cells in X-linked lymphoproliferative syndrome. Blood 2018;131:699-702.

  30. Penniment MG, De Ieso PB, Harvey JA, Stephens S, Au HJ, O'Callaghan CJ, Kneebone A, Ngan SY, Ward IG, Roy R, Smith JG, Nijjar T, Biagi JJ, Mulroy LA, Wong R, group TCE. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01). Lancet Gastroenterology & Hepatology 2018;3:114-24.

  31. Perera M, Papa N, Christidis D, McGrath S, Manning T, Roberts M, Bolton D, Lawrentschuk N, Sengupta S. The impact of the global bacille Calmette-Guerin shortage on treatment patterns: population-based data. BJU International 2018;121:169-72.

  32. Quach H, Benson S, Haysom H, Wilkes AM, Zacher N, Cole-Sinclair M, Miles Prince H, Mollee P, Spencer A, Joy Ho P, Harrison SJ, Lee C, Augustson B, Daly J. Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma. Internal Medicine Journal 2018;48:210-20.

  33. Rogers TW, Toor G, Drummond K, Love C, Field K, Asher R, Tsui A, Buckland M, Gonzales M. The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas. Journal of Neuro-Oncology 2018;137:181-9.

  34. Ross DM, Arthur C, Burbury K, Ko BS, Mills AK, Shortt J, Kostner K. Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factors. Internal Medicine Journal 2018;48 Suppl 2:5-13.

  35. Rubin AF, Gelman H, Lucas N, Bajjalieh SM, Papenfuss AT, Speed TP, Fowler DM. Correction to: A statistical framework for analyzing deep mutational scanning data. Genome Biology 2018;19:17.

  36. Ryland GL, Jones K, McBean M, Khot A, Seymour JF, Blombery P. Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestry. Leukemia & Lymphoma 2018;59:992-5.

  37. Sathianathen NJ, Christidis D, Konety BR, Lawrentschuk NL. Magnetic resonance imaging cognitive fusion biopsy - is near enough good enough? BJU International 2018;121:324-6.

  38. Semenec L, Laloo AE, Schulz BL, Vergara IA, Bond PL, Franks AE. Deciphering the electric code of Geobacter sulfurreducens in cocultures with Pseudomonas aeruginosa via SWATH-MS proteomics. Bioelectrochemistry 2018;119:150-60.

  39. Sonnenblick A, Salgado R, Brohee S, Zahavi T, Peretz T, Van den Eynden G, Rouas G, Salmon A, Francis PA, Di Leo A, Crown JPA, Viale G, Daly L, Javdan B, Fujisawa S, De Azambuja E, Lieveke A, Piccart MJ, Bromberg JF, Sotiriou C. p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial. International Journal of Oncology 2018;52:424-32.

  40. Teh BW, Brown C, Joyce T, Worth LJ, Slavin MA, Thursky KA. Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre. Supportive Care in Cancer 2018;26:997-1003.

  41. Teh TC, Nguyen NY, Moujalled DM, Segal D, Pomilio G, Rijal S, Jabbour A, Cummins K, Lackovic K, Blombery P, Thompson E, Ekert PG, Lessene G, Glaser SP, Huang DCS, Roberts AW, Guthridge MA, Wei AH. Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1. Leukemia 2018;32:303-12.

  42. Thai AA, Solomon BJ. Treatment of ALK-positive nonsmall cell lung cancer: recent advances. Current Opinion in Oncology 2018;30:84-91.

  43. Thang SP, Lung MS, Kong G, Hofman MS, Callahan J, Michael M, Hicks RJ. Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging 2018;45:323.

  44. Thang SP, Lung MS, Kong G, Hofman MS, Callahan J, Michael M, Hicks RJ. Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging 2018;45:262-77.

  45. Turner J, Mackenzie L, Kelly B, Clarke D, Yates P, Aranda S. Building psychosocial capacity through training of front-line health professionals to provide brief therapy: lessons learned from the PROMPT study. Supportive Care in Cancer 2018;26:1105-12.

  46. Urbancic KF, Ierino F, Phillips E, Mount PF, Mahony A, Trubiano JA. Taking the challenge: A protocolized approach to optimize Pneumocystis pneumonia prophylaxis in renal transplant recipients. American Journal of Transplantation 2018;18:462-6.

  47. Valpione S, Carlino MS, Mangana J, Mooradian MJ, McArthur G, Schadendorf D, Hauschild A, Menzies AM, Arance A, Ascierto PA, Di Giacomo A, de Rosa F, Larkin J, Park JJ, Goldinger SM, Sullivan RJ, Xu W, Livingstone E, Weichenthal M, Rai R, Gaba L, Long GV, Lorigan P. Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study. European Journal of Cancer 2018;91:116-24.

  48. Villemagne Sanchez LA, O'Callaghan C, Gough K, Hall K, Kashima Y, Seymour JF, Schofield P, Ross DM. Patient perceptions of treatment-free remission in chronic myeloid leukemia. Leukemia & Lymphoma 2018;59:406-15.

  49. Wainer Z, Wright GM, Gough K, Daniels MG, Choong P, Conron M, Russell PA, Alam NZ, Ball D, Solomon B. Impact of sex on prognostic host factors in surgical patients with lung cancer. ANZ Journal of Surgery 2017;87:1015-20.

  50. Wiley G, Piper A, Phyllis Butow AM, Schofield P, Douglas F, Roy J, Nolte L, Jefford M. Developing Written Information for Cancer Survivors from Culturally and Linguistically Diverse Backgrounds: Lessons Learnt. Asia Pac J Oncol Nurs 2018;5:121-6.

  51. Williams T, Ngo LH, Wickramasinghe VO. Nuclear export of RNA: Different sizes, shapes and functions. Seminars in Cell & Developmental Biology 2018;75:70-7.

  52. Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. Annals of Surgical Oncology 2018;25:356-77.

  53. Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology 2018;36:399-413.

  54. Zivanovic Bujak A, Dawson SJ. Circulating Tumor DNA Guides Prognosis in Metastatic Triple-Negative Breast Cancer. Journal of Clinical Oncology 2018;36:523-4.

Health Sciences Library [MAP]

PO Royal Melbourne Hospital

PARKVILLE, VIC 3050, AUSTRALIA

Phone: (03) 9342 8617; Fax: (03) 9342 8615

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Learning Resource Centre [MAP]

Level 7A, Peter MacCallum Cancer Centre

305 Grattan Street

MELBOURNE, VIC 3000, AUSTRALIA

Phone: (03) 8559 7194

 

Library Manager

Susan Monaghan;

Phone: (03) 9342 7346

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Health Sciences Library (RMH Building)

Hours (February - November):

Monday - Thursday: 8.30am - 6pm

Friday: 8.30am - 5pm

Summer Hours (December - January):

Monday - Friday: 8:30am - 5pm 


Learning Resource Centre (Peter MacCallum Building)

Staffed Hours (January - December):

Monday - Thursday: 10am - 2pm